Sanofi (SAN.PA)
EUR 91.8
(0.07%)
EUR 91.8
(0.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 11.99 Billion EUR | -7.84% |
| 2022 | 14.06 Billion EUR | 30.66% |
| 2021 | 11.29 Billion EUR | 10.23% |
| 2020 | 17.51 Billion EUR | -0.78% |
| 2019 | 7.11 Billion EUR | 5.09% |
| 2018 | 9.36 Billion EUR | -8.92% |
| 2017 | 10.28 Billion EUR | -0.76% |
| 2016 | 10.35 Billion EUR | 1.22% |
| 2015 | 10.23 Billion EUR | 3.7% |
| 2014 | 9.86 Billion EUR | 2.61% |
| 2013 | 9.61 Billion EUR | -23.06% |
| 2012 | 11.43 Billion EUR | 17.48% |
| 2011 | 10.64 Billion EUR | -6.66% |
| 2010 | 11.4 Billion EUR | 0.26% |
| 2009 | 11.4 Billion EUR | 13.62% |
| 2008 | 10.48 Billion EUR | -3.8% |
| 2007 | 10.4 Billion EUR | -16.53% |
| 2006 | 12.11 Billion EUR | -6.95% |
| 2005 | 11.66 Billion EUR | 494.27% |
| 2004 | 2.25 Billion EUR | -29.29% |
| 2003 | 3.18 Billion EUR | 14.03% |
| 2002 | 2.99 Billion EUR | 16.12% |
| 2001 | 2.4 Billion EUR | 32.4% |
| 2000 | 1.81 Billion EUR | 50.62% |
| 1999 | 1.2 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.86 Billion EUR | 74.0% |
| 2024 Q2 | 2.51 Billion EUR | -12.28% |
| 2024 Q3 | 4.24 Billion EUR | 69.2% |
| 2023 Q3 | 4.16 Billion EUR | 46.84% |
| 2023 Q4 | 5.94 Billion EUR | 43.0% |
| 2023 Q1 | 3.57 Billion EUR | 47.99% |
| 2023 FY | - EUR | -7.84% |
| 2023 Q2 | 2.83 Billion EUR | -20.8% |
| 2022 Q4 | 2.41 Billion EUR | -54.6% |
| 2022 Q1 | 3.24 Billion EUR | 69.74% |
| 2022 Q3 | 5.32 Billion EUR | 88.58% |
| 2022 FY | - EUR | 30.66% |
| 2022 Q2 | 2.82 Billion EUR | -12.99% |
| 2021 Q3 | 3.92 Billion EUR | 59.58% |
| 2021 Q4 | 1.91 Billion EUR | -51.3% |
| 2021 FY | - EUR | 10.23% |
| 2021 Q2 | 2.45 Billion EUR | -17.29% |
| 2021 Q1 | 2.97 Billion EUR | 43.19% |
| 2020 Q2 | 2.25 Billion EUR | -22.08% |
| 2020 FY | - EUR | -0.78% |
| 2020 Q4 | 2.07 Billion EUR | -39.66% |
| 2020 Q1 | 2.89 Billion EUR | 71.4% |
| 2020 Q3 | 3.44 Billion EUR | 52.7% |
| 2019 Q4 | 1.68 Billion EUR | -49.04% |
| 2019 FY | - EUR | 5.09% |
| 2019 Q3 | 3.31 Billion EUR | 39.53% |
| 2019 Q1 | 2.5 Billion EUR | 56.69% |
| 2019 Q2 | 2.37 Billion EUR | -5.43% |
| 2018 FY | - EUR | -8.92% |
| 2018 Q3 | 3.08 Billion EUR | 46.54% |
| 2018 Q1 | 2.25 Billion EUR | 8.32% |
| 2018 Q2 | 2.1 Billion EUR | -6.61% |
| 2018 Q4 | 1.6 Billion EUR | -48.02% |
| 2017 Q4 | 2.07 Billion EUR | -34.57% |
| 2017 Q2 | 2.65 Billion EUR | 3.42% |
| 2017 Q1 | 2.56 Billion EUR | 12.0% |
| 2017 FY | - EUR | -0.76% |
| 2017 Q3 | 3.17 Billion EUR | 19.72% |
| 2016 Q3 | 3.31 Billion EUR | 40.88% |
| 2016 Q4 | 2.29 Billion EUR | -30.94% |
| 2016 Q2 | 2.35 Billion EUR | -5.75% |
| 2016 Q1 | 2.49 Billion EUR | 76.15% |
| 2016 FY | - EUR | 1.22% |
| 2015 Q2 | 2.53 Billion EUR | -8.0% |
| 2015 Q1 | 2.75 Billion EUR | 49.5% |
| 2015 Q3 | 3.17 Billion EUR | 25.32% |
| 2015 Q4 | 1.41 Billion EUR | -55.29% |
| 2015 FY | - EUR | 3.7% |
| 2014 Q3 | 2.98 Billion EUR | 25.08% |
| 2014 Q1 | 2.5 Billion EUR | 5.64% |
| 2014 Q4 | 1.84 Billion EUR | -38.29% |
| 2014 FY | - EUR | 2.61% |
| 2014 Q2 | 2.38 Billion EUR | -4.98% |
| 2013 Q4 | 2.37 Billion EUR | -18.55% |
| 2013 FY | - EUR | -23.06% |
| 2013 Q3 | 2.91 Billion EUR | 38.09% |
| 2013 Q2 | 2.11 Billion EUR | -22.4% |
| 2013 Q1 | 2.72 Billion EUR | 7.85% |
| 2012 FY | - EUR | 17.48% |
| 2012 Q2 | 3.04 Billion EUR | 2.32% |
| 2012 Q3 | 3.51 Billion EUR | 15.37% |
| 2012 Q1 | 2.97 Billion EUR | 12.35% |
| 2012 Q4 | 2.52 Billion EUR | -28.12% |
| 2011 Q3 | 3.24 Billion EUR | 31.14% |
| 2011 FY | - EUR | -6.66% |
| 2011 Q1 | 2.27 Billion EUR | 4.94% |
| 2011 Q2 | 2.47 Billion EUR | 9.03% |
| 2011 Q4 | 2.64 Billion EUR | -18.48% |
| 2010 Q1 | 3.06 Billion EUR | -64.61% |
| 2010 Q2 | 3.12 Billion EUR | 1.96% |
| 2010 Q3 | 3.05 Billion EUR | -2.15% |
| 2010 Q4 | 2.16 Billion EUR | -29.14% |
| 2010 FY | - EUR | 0.26% |
| 2009 Q2 | 3.09 Billion EUR | 4.08% |
| 2009 Q4 | 8.65 Billion EUR | 885.19% |
| 2009 Q1 | 2.96 Billion EUR | 71.72% |
| 2009 FY | - EUR | 13.62% |
| 2009 Q3 | 878 Million EUR | -71.59% |
| 2008 Q2 | 2.52 Billion EUR | -0.03% |
| 2008 Q3 | 2.71 Billion EUR | 7.53% |
| 2008 FY | - EUR | -3.8% |
| 2008 Q4 | 1.72 Billion EUR | -36.2% |
| 2008 Q1 | 2.52 Billion EUR | 116.77% |
| 2007 Q1 | 7.05 Billion EUR | 143.83% |
| 2007 Q4 | -15.03 Billion EUR | -315.67% |
| 2007 Q3 | 6.96 Billion EUR | 175.14% |
| 2007 Q2 | 2.53 Billion EUR | -64.1% |
| 2007 FY | - EUR | -16.53% |
| 2006 FY | - EUR | -6.95% |
| 2006 Q4 | -16.09 Billion EUR | -318.87% |
| 2006 Q3 | 7.35 Billion EUR | 201.73% |
| 2006 Q2 | 2.43 Billion EUR | -36.32% |
| 2006 Q1 | 3.82 Billion EUR | 304.93% |
| 2005 Q1 | 4.05 Billion EUR | 140.47% |
| 2005 Q2 | 2.73 Billion EUR | -32.44% |
| 2005 FY | - EUR | 494.27% |
| 2005 Q4 | -1.86 Billion EUR | -140.09% |
| 2005 Q3 | 4.65 Billion EUR | 70.24% |
| 2004 Q4 | -10.01 Billion EUR | -287.64% |
| 2004 Q2 | 829.67 Million EUR | -62.75% |
| 2004 Q3 | 5.33 Billion EUR | 543.01% |
| 2004 Q1 | 2.22 Billion EUR | 169.76% |
| 2004 FY | - EUR | -29.29% |
| 2003 Q2 | 697.02 Million EUR | -64.18% |
| 2003 FY | - EUR | 14.03% |
| 2003 Q4 | -3.19 Billion EUR | -232.07% |
| 2003 Q1 | 1.94 Billion EUR | 165.94% |
| 2003 Q3 | 2.41 Billion EUR | 246.82% |
| 2002 Q4 | -2.95 Billion EUR | -257.68% |
| 2002 FY | - EUR | 16.12% |
| 2002 Q2 | 601.94 Million EUR | 0.0% |
| 2002 Q3 | 1.87 Billion EUR | 210.89% |
| 2001 FY | - EUR | 32.4% |
| 2000 FY | - EUR | 50.62% |
| 1999 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Virbac SA | 216.45 Million EUR | -5442.517% |